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Abstract
OBJECTIVE: This study was conducted to evaluate
the effect of Amomum villosum on longitudinal
bone growth.
METHODS: Adolescent female Sprague-Dawley
rats were divided into 3 groups and treated for 4
days: control (distilled water, p.o.), recombinant
human growth hormone (rhGH; 100 μg/kg, s.c.),
and A. villosum (500 mg/kg, p.o.) groups. On day 3,
tetracycline (20 g/kg, i.p.) was injected for growth
plate identification. On days 2, 3 and 4,
5-bromo-2'-deoxyuridine (BrdU) (50 mg/kg, i.p.)
was injected to label proliferating cells. On day 5,
tibias were dissected and fixed in 4%
paraformaldehyde, dehydrated, and sectioned for
immunohistochemistry and histomorphometry.
RESULTS: The rate of bone growth in the A.
villosum and rhGH groups increased to (410 ± 44)
and (389 ± 46) μm/day (P<0.01), respectively, as
compared with the control (330.7 ± 34.7) μm/day.
The thickness of the growth plates also increased
to (591 ± 37) and (598 ± 32) μm, respectively, as
compared with the control (524±89) μm (P<0.001).
The number of BrdU-positive cells in the
chondrocytes of the A. villosum and rhGH groups
was also significantly higher (126±24) and (143±18)
cells/mm2, respectively) than in the control (109 ±
25) mm2 (P<0.05). Insulin-like growth factor-1 and
bone morphogenetic protein-2 in the A. villosum
and rhGH groups were highly expressed in the
growth plate as compared with the control
samples, indicating increased bone formation.
CONCLUSIONS: A. villosum could be used to treat
growth retardation during adolescence.
© 2012 JTCM. All rights reserved.
Keywords: Amomum villosum; Growth plate; Bone
Development; Recombinant human growth
hormone
INTRODUCTION
A major factor controlling height is bony growth,
which stimulates other tissue growth depending on the
framework of the body. Bones in different parts of the
skeleton develop through two distinct processes,
intramembranous ossification and endochondral
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ossification. Endochondral ossification in the growth
plate leads to longitudinal bone growth, involving
replacement of a cartilage model with bone tissue.
After birth, much of bony elongation occurs through
the activity of chondrocytes within the growth plate,
which are continually replaced by bone-forming cells
through a combination of proliferation, cartilage
extracellular matrix secretion, and hypertrophy. An
important stimulator of chondrocyte proliferation in
the growth plate is growth hormone (GH), which is
activated through stimulation of insulin-like growth
factor (IGF)-1. Furthermore, chondrocyte proliferation
is also regulated through the activation of bone
morphogenetic protein (BMP) signaling in the bone
growth plate.1 Observations of chondrocyte
proliferation, IGF-1, and BMP concentrations are
useful indicators of the degree of growth.
The Amomum plant is one of the most ancient and
highly valued spices in the world. Amomum villosum
(Zingiberaceae), native to Guangdong province, is a
perennial herb that occurs in the understory of tropical
and subtropical forests2 and is an important medicinal
plant for improvement of gastrointestinal motility.3
Few reports have been published the effects of A.
villosum on longitudinal body growth. However, in
Dongeuibogam, the traditional book of Korean
medicine, malnutrition associated with growth
retardation was treated using an herbal mixture
containing A. villosum.
In this study, the effects of A. villosum on longitudinal
bone growth were determined in the epiphyseal plates
of Sprague-Dawley rats. BrdU (5-bromo-2'-
deocyuridine), a thymidine analogue incorporated into
DNA during replication,4 was used to determine
proliferation, and tetracycline labeling for growth plate
identification. Furthermore, the expressions of BMP-2
and IGF-1 were studied using immunohistochemistry.
METHODS
Animals
Four-week-old female Sprague-Dawley rats, weighing
(80±10)g, were used in this study (Samtako Co., Osan,
Korea). The experimental procedures were performed
in accordance with the animal care guidelines of
Kyung Hee University's Institutional Animal Care and
Use Committee [protocol number KHUASP(SE)
2011-008). Animals were housed 5/cage under
controlled temperature (23 ± 2)° C, relative humidity
[55 ± 10)% ], and lighting (lights on 07:00-19:00 h),
with food and water made available ad libitum. After 1
week of acclimatization, the rats were split into their
respective groups for treatment.
Preparation of amomum villosum water extract
The fruit of Amomum villosum was collected in
Guangdong, China (KH Herb Pharm., Seoul, Korea).
The dried plant (200 g) was extracted twice with
distilled water in 3 h of reflux heating. The filtrates
were evaporated by rotary evaporator and lyophilized
by a freeze-dryer (Operon ™, Seoul, Korea). The
powder was stored at -20°C until it was needed. The
yield of the freeze-dried product of A. villosum was
about 10.71%.
Treatment groups
Animals were randomly allocated into 3 groups
according to supplement regimen. Distilled water
(DW; 10 rats) or A. villosum (500 mg/kg; 10 rats) was
administered orally twice daily at 8:00 and 20:00 h in
a fixed dose volume of 10.0 ml/kg. Recombinant
human growth hormone (rhGH) (100 μg/kg; 10 rats)
(LG Life Science, Seoul) was subcutaneously injected
once daily. Treatment was continued for 4 consecutive
days. On day 3, all animals were injected intra-
peritoneally with tetracycline hydrochloride (20 mg/kg,
Sigma, St. Louis, MO, USA) in saline for the
measurement of bone growth. On days 2, 3, and 4,
5-bromo-2'-deoxyuridine (BrdU) (50 mg/kg, Sigma)
was intraperitoneally injected to label proliferating
cells. Twenty-four h after the final injection, animals
were sacrificed, and then the tibias were dissected free
from the soft tissues.5
Tissue preparation and detection of longitudinal
bone growth
The dissected tibias were fixed in 4% para-
formaldehyde for 48 h and dehydrated by immersion
in 30% sucrose for 1 day.6 Dehydrated bone was
longitudinally sectioned at a thickness of 40 μm with a
microtome (Leica, Berlin, Germany).7 The sections
were mounted onto gelatinized glass slides and
observed by fluorescence microscopy (Olympus,
Tokyo, Japan). The longitudinal bone length between
the fluorescent line and the epiphyseal end line of the
growth plate at three different locations using Image J
version 1.43 u (National Institutes of Health, USA). 8
Data were averaged to calculate the longitudinal bone
growth rates.
Detection of chondrocyte proliferation
For the detection of cell proliferation in the growth
plate, BrdU-specific immunofluorescence was per-
formed.9 Dehydrated tibial sections were pretreated in
2 M HCl at 37°C for 1 h and rinsed twice in 0.1 M
sodium borate (pH 8.5). The sections were incubated
in phosphate-buffered saline (PBS), including 3%
bovine serum albumin and 0.3% Triton X-100 for 1
hour and incubated with BrdU-specific mouse
monoclonal antibody (Santa Cruz Biotechnology,
Santa Cruz, CA, USA) (diluted 1∶100) overnight at
4° C. The sections were then washed 3 times with
0.1 M PBS before incubation with fluorescein
isothiocyanate-conjugated mouse secondary antibody
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(Jackson Imm- unResearch Laboratories, Bar Harbor,
ME, USA) (diluted 1∶ 200) for 4 h at room
temperature. Finally, the sections were washed with
PBS and mounted onto gelatinized glass slides. To
measure the number of BrdU-positive cells,
fluorescence images of the sections were collected using
fluorescence microscopy (Olympus, Tokyo, Japan).
The mean density of BrdU-labeled cells in each rat was
calculated as the number of BrdU-labeled nuclei per
area (in mm2) in the growth plate, as measured by two
independent observers.10
Measurement of BMP-2 and IGF-1 in the growth
plates
For the detection of BMP-2 and IGF-1 in the growth
plate, the dehydrated tibial sections were incubated in
1% Triton X-100 at room temperature and incubated
with goat BMP-2 antibody or rabbit IGF-1 antibody
(Santa Cruz Biotechnology) (diluted 1:200) overnight
at 4° C. The sections were then incubated with anti-
goat and anti-rabbit antibodies (Jackson Immun-
oResearch Laboratories) (diluted 1:200) for 60 min,
respectively, and then stained with 0.05% 3,
3-diaminobenzidine.7
Statistical analysis
Results are expressed as the mean±SD of the different
experiments under the same conditions. Statistically
significant values were compared using Student's t test
for comparisons between groups. P-values<0.05 were
considered statistically significant.
RESULTS
Daily body weight change
On days 1-5, the daily body weights of the rats in the
control, rhGH and A. villosum group are described in
Table 1. From the 1st day to the 5th day, the body
weight gain was (18.8±1.5) g (control), (19.1±1.7) g
(rhGH), and (17.5 ± 1.7) g (A. villosum). The weight
for the rats in the A. villosum treatment group
increased slower than the other two groups, but this
difference was not statistically significant (Figure 1).
To evaluate the rate of longitudinal bone growth,
tetracycline was used to label the newly formed bone
(Figure 2). The longitudinal bone growth of the
control adolescent female rats was (331±35) μm/day.
The rhGH group showed a significantly greater rate of
bone growth of (389 ± 46) μm/day as compared with
the control group (P=0.0050). The A. villosum group
also showed a significantly greater rate of bone growth
of (410 ± 44) μm/day as compared with the control
group (P=0.0003) (Figure 3).
The proximal tibial growth plate in the control group
was approximately (524 ±89) μm thick. Following A.
villosum administration, the growth plate thickness
increased to (591±37) μm (P=0.0007). For rats in the
rhGH group, the growth plate thickness increased to
(598±32) μm (P=0.0002) (Figure 4).
BrdU-labeled cells were observed in the chondrocytes
to determine the proliferation levels in the growth
plates (Figure 5). The number of BrdU-positive cells in
the control group was (110 ± 25) cells/mm2. In the
rhGH group, the number of BrdU-positive cells
increased to (143 ± 18) cells/mm2 (P<0.0001). The
number of BrdU-positive cells in the A. villosum group
also increased to (126±24) cells/mm2 (P=0.02) (Figure
6).
To investigate the expression of BMP-2 and IGF-1,
25
20
15
10
5
0
Control rhGH HP349
100 μg/kg 500 mg/kg
s.c. p.o.
Bo
dy
we
igh
tg
ain
(g)
Figure 1 Effect on weight gain over 5 days
Control: DW group. rhGH: recombinant human
growth hormone (100 μg/kg, s.c.) group. A. villosum:
Amomum villosum (500 mg/kg, p.o.) group. Each
value is the mean±SD of 10 rats. Statistical significance
was determined using a t test: no significant differences
compared with the control.
Group
Control
rhGH
A. villosum
Body weight (g)
1st day
79±3
80±4
80±3
2nd day
86±3
86±5
86±4
3rd day
93±3
93±6
92±4
4th day
99±4
98±5
98±4
5th day
105±4
106±5
103±4
Table 1 The body weight changes in adolescent female rats
Notes: Control: distilled water group. rhGH: recombinant human growth hormone (100 μg/kg, s.c.) group. A. villosum: Amomum
villosum (500 mg/kg, p.o.) group. Each value is the mean±SD of 10 rats. Statistical significance was determined using a t test: no
significant differences compared with the control.
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immunohistochemistry in the growth plate was
performed. BMP-2 was highly expressed in the
proliferative and hypertrophic zones in the rhGH
group but was minimally expressed in the resting zones
(Figure 7). IGF-1 expression was relatively higher in
the proliferative and hypertrophic zones than in the
resting zones (Figure 8). BMP-2 and IGF-1 expression
of the A. villosum group was lower than those
expressions in the rhGH group, but higher than those
expressions in the control group.
DISCUSSION
Amomum villosum increases longitudinal bone growth
in adolescent female rats. A. villosum significantly
increased the tibial growth rate by 24.07% compared
to normal rats (P<0.001). This rate was more than the
17.60% of the rhGH (P<0.01), which has been known
to enhance tibial growth in peripubertal female rats.11
In addition, the daily body weight changes over 5 days
were not significantly different among the groups. A.
villosum is thought to be effective for bone growth and
is not associated with extra weight gain.
The thickness of the growth plate is direct evidence of
longitudinal bone growth.12 In the A. villosum group,
the thickness of the growth plate was significantly
increased as compared with the controls (P<0.001). A.
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Figure 3 Effect on longitudinal bone growth
Control: DW group. rhGH: recombinant human growth
hormone (100 μg/kg, s.c.) group. A. villosum: Amomum
villosum (500 mg/kg, p.o.) group. Each value is the mean±
SD of 10 rats. Statistical significance was determined using t
test: bP<0.01, cP<0.001, compared with the control.
800
600
400
200
0
Control rhGH A. villosum
100 μg/kg 500 mg/kg
s.c. p.o.
Gr
ow
th
pla
te
thi
ckn
ess
(μm
) bb
Figure 4 Effect on growth plate thickness
Control: DW group. rhGH: recombinant human growth
hormone (100 μg/kg, s.c.) group. A. villosum: Amomum
villosum (500 mg/kg, p.o.) group. Each value is the mean±
SD of 10 rats. Statistical significance was determined using a
t test: bP<0.001, compared with the control.
Figure 5 Representative images of 5-bromo-2'-deoxyuridine (BrdU)-labeled chondrocytes in the growthplates of the proximal tibia
Control: DW group. rhGH: recombinant human growth hormone (100 μg/kg, s.c.) group. A. villosum: Amomum villosum (500 mg/
kg, p.o.) group. Green, BrdU-labeled chondrocyte. Scale bar = 100 μm.
Figure 2: Fluorescent photomicrographs of longitudinal sections at the proximal tibia in the proximal tibia growth plate
Control: DW group. rhGH: recombinant human growth hormone (100 μg/kg, s.c.) group. A. villosum: Amomum villosum (500 mg/
kg, p.o.) group. The fluorescent line corresponds to the injection of tetracycline hydrochloride (20 mg/kg), which binds with
calcium and can be detected by ultraviolet illumination. The arrow between the fluorescent line formed by tetracycline and the
epiphyseal end line of the growth plate indicates the bone growth during the 24-hour period. Scale bar=200 μm.
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villosum increased the growth plate thickness,
demonstrating the growth potential.13
BrdU is incorporated into DNA during the S-phase
and can be detected by immunohistochemistry.4 A
higher number of BrdU-labeled cells, the greater the
number of proliferating chondrocytes. The number of
BrdU-positive cells in the rhGH and A. villosum
groups was 1.31-fold (P<0.001) and 1.15-fold (P<
0.05) greater than that of the control group. This result
suggests that A. villosum induces cell proliferation in
chondrocytes.
The growth plate can be divided into three
histologically distinct layers—the resting zone, the
proliferative zone, and the hypertrophic zone. The
topmost layer, the resting zone, contains chondrocytes
that are scattered in a cartilage matrix bed and that
divide infrequently in postnatal life.14 The resting zone
chondrocytes serve as stem-like cells for the growth
plate, with the potential to generate clones of rapidly
proliferating chondrocytes, which are located in the
proliferative zone in the second layer of the growth
plate.15 In the proliferative zone, these clones of
chondrocytes are arranged in columns parallel to the
long axis of the bone. Over time, as longitudinal
growth proceeds, proliferative cells close to the
hypertrophic zone undergo terminal differentiation.
During this process, they stop proliferating and
physically enlarge to become hypertrophic
chondrocytes, composing the third, hypertrophic layer
of the growth plate. Simultaneously, the bottom of the
hypertrophic zone is invaded by blood vessels,
osteoclasts, and differentiating osteoblasts, which
remodel the newly formed cartilage into bone tissue.16
BMP-2 and IGF-1 were highly expressed in the
proliferative and hypertrophic zones after A. villosum
treatment. BMP is a member of the transforming
growth factor (TGF)-β family, acting as both a growth
and differentiation factor.17 Of the various forms of
BMP, BMP-2 plays an important role in the
development of the epiphyseal growth plate.18While
TGF-β is unable to initiate the entire osteoinduction
cascade by itself, BMP-2 uniquely exhibits an ectopic
bone formation property.19 IGF-1 is a growth factor
structurally related to insulin that induces subsequent
cellular activities, particularly those related to bone
growth. Involved in the expression mechanism of
growth hormone, IGF-1 regulates cell differentiation,
proliferation, and maturation in most parts of the body
by autocrine and paracrine activities. The mechanism
of IGF-1 action in promoting structural growth
involves 'insulin-like' anabolic effects, supporting the
200
150
100
50
0 Control rhGH A. villosum
100 μg/kg 500 mg/kg
s.c. p.o.
Brd
U-
po
sit
ive
cel
ls(
N/
mm
2 )
c a
Figure 6 Effect on BrdU-positive cells
Control: DW group. rhGH: recombinant human growth
hormone (100 μg/kg, s.c.) group. A. villosum: Amomum
villosum (500 mg/kg, p.o.) group. Each value is the mean±
SD of 10 rats. Statistical significance was determined using t
test: aP<0.05, cP<0.001, compared with the control.
Control rhGH A. villosum
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Figure 7 Immunohistochemical localization of bone
morphogenetic protein-2 in the growth plate
Control: DW group. rhGH: recombinant human growth
hormone (100 μg/kg, s.c.) group. A. villosum: Amomum
villosum (500 mg/kg, p.o.) group. RZ: resting zone, PZ:
proliferative zone, HZ: hypertrophic zone. Scale bar=100 μm.
Control rhGH A. villosum
RZ
PZ
HZ
Figure 8 Immunohistochemical localization of insulin-like
growth factor-1 in the growth plate
Control: DW group. rhGH: recombinant human growth
hormone (100 μg/kg, s.c.) group. A. villosum: Amomum
villosum (500 mg/kg, p.o.) group. RZ: resting zone, PZ:
proliferative zone, HZ: hypertrophic zone. Scale bar=100 μm.
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extraordinary biosynthetic activity, somatic growth,
and matrix production that characterize hypertrophic
chondrocytes.20 The expressions of BMP-2 and IGF-1
directly represent the proliferative activity of cartilage.
Tibial growth rate of A. villosum was greater than that
of rhGH, but the thickness of the growth plate, the
number of BrdU-positive cells, and BMP-2 and IGF-1
expressions of A. villosum did not exceed those of
rhGH. Thus, A. villosum cannot be an alternative to
GH treatment for short stature. However, long-term
GH treatment is expensive, and the final height gains
are small as compared with those of non-GH-deficient
children.21 GH appears to be relatively safe, but its
long-term effects are not yet fully known, and some
adverse effects have been reported, including edema
andpseudotumor cerebri, gynecomastia, hyperinsulinism
or elevated blood glucose level, and a potential increase
in nevi.22 A. villosum might be an alternative treatment
which meets the cost-benefit qualification while
avoiding the potential risks of GH therapy.
A. villosum stimulated chondrocyte proliferation and
chondrocyte hypertrophy in the growth plate through
the generation of BMP-2 and IGF-1, as well as directly
increasing the longitudinal tibial length. Therefore, A.
villosum could be helpful for increasing bone growth
in children with growth retardation. Further studies are
needed to identify the active components of A.
villosum that can provide confirmation of growth
promotion, and to better understand the mechanisms
in this process.
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